European biotech flourishes as US and Asian capital pours in
Despite benefiting from five times less investment compared with the US, the European biotech sector has blossomed in recent years, attracting increasing financing from a diversified mix of investors and producing several healthcare unicorns. Alessia Argentieri reports
More on Investments
SDG500 launched to invest in developing countries
Fund invests debt and equity in seed, series-A and series-B rounds in emerging and frontier markets
Unquote Private Equity Podcast: the Review/Preview special
In this special bumper episode, the Unquote editorial team does a deep dive on key 2019 stats in each market
Corporate divestments fuel European buyouts
Carve-outs and spin-outs represented around 14% of all buyouts in 2019, up from 11.5% in 2018 and 10% in 2017, according to Unquote Data
Unquote Private Equity Podcast: Craving carve-outs
Listen to the latest episode of the Unquote Private Equity Podcast, where the team discusses corporate carve-outs
Latest News
Rhône Capital exits Milan-listed Unieuro
Total proceeds from Rhône Capital's investment in Unieuro amount to approximately €202m
MW&L acquires Chairman Mentors
MW&L invested £66m in oil well decommissioning company Well-Safe Solutions in October 2019
Equistone-backed PIA buys Nordpol+
GP has been pursuing a buy-and-build strategy for the advertising company since 2014
Nazca Capital appoints two new partners
Nazca also hires Olga San Jacinto as a member of the firm's industrial advisory board